Consequences of Metabolic Disruption in Alzheimer's Disease Pathology.

Ryu, J C; Zimmer, E R; Rosa-Neto, P; Yoon, S O

Ryu, J C; Zimmer, E R; Rosa-Neto, P; Yoon, S O.

Ryu JC; Department of Biological Chemistry & Pharmacology, Ohio State University, Columbus, OH, USA.
Zimmer ER; Department of Pharmacology, UFRGS, Porto Alegre, Brazil.
Rosa-Neto P; Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
Yoon SO; Graduate Program in Biological Sciences: Pharmacology and Therapeutics, UFRGS, Porto Alegre, Brazil.

Neurotherapeutics ; 16(3): 600-610, 2019 07.

Article en En | MEDLINE | ID: mdl-31270743

Asunto(s)

Enfermedad de Alzheimer/etiología; Enfermedades Metabólicas/complicaciones; Enfermedad de Alzheimer/metabolismo; Animales; Encéfalo/metabolismo; Trastornos Cronobiológicos/complicaciones; Trastornos Cronobiológicos/metabolismo; Glucosa/metabolismo; Humanos; Leptina/metabolismo

Palabras clave

Alzheimer's disease; Brain hypometabolism; Circadian rhythm; Insulin resistance; Leptin resistance; Type 2 diabetes

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Enfermedades Metabólicas Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google